Suppr超能文献

对与帕金森病相关的孤儿受体GPR6的高基础活性和反向激动作用的结构见解。

Structural insights into the high basal activity and inverse agonism of the orphan receptor GPR6 implicated in Parkinson's disease.

作者信息

Barekatain Mahta, Johansson Linda C, Lam Jordy H, Chang Hao, Sadybekov Anastasiia V, Han Gye Won, Russo Joseph, Bliesath Joshua, Brice Nicola L, Carlton Mark B L, Saikatendu Kumar S, Sun Hukai, Murphy Sean T, Monenschein Holger, Schiffer Hans H, Popov Petr, Lutomski Corinne A, Robinson Carol V, Liu Zhi-Jie, Hua Tian, Katritch Vsevolod, Cherezov Vadim

机构信息

Bridge Institute, USC Michelson Center for Convergent Biosciences, University of Southern California, Los Angeles, CA 90089, USA.

Department of Chemistry, University of Southern California, Los Angeles, CA 90089, USA.

出版信息

Sci Signal. 2024 Dec 3;17(865):eado8741. doi: 10.1126/scisignal.ado8741.

Abstract

GPR6 is an orphan G protein-coupled receptor with high constitutive activity found in D2-type dopamine receptor-expressing medium spiny neurons of the striatopallidal pathway, which is aberrantly hyperactivated in Parkinson's disease. Here, we solved crystal structures of GPR6 without the addition of a ligand (a pseudo-apo state) and in complex with two inverse agonists, including CVN424, which improved motor symptoms in patients with Parkinson's disease in clinical trials. In addition, we obtained a cryo-electron microscopy structure of the signaling complex between GPR6 and its cognate G heterotrimer. The pseudo-apo structure revealed a strong density in the orthosteric pocket of GPR6 corresponding to a lipid-like endogenous ligand. A combination of site-directed mutagenesis, native mass spectrometry, and computer modeling suggested potential mechanisms for high constitutive activity and inverse agonism in GPR6 and identified a series of lipids and ions bound to the receptor. The structures and results obtained in this study could guide the rational design of drugs that modulate GPR6 signaling.

摘要

GPR6是一种孤儿G蛋白偶联受体,具有高组成性活性,存在于纹状体苍白球通路中表达D2型多巴胺受体的中型多棘神经元中,在帕金森病中该受体异常过度激活。在此,我们解析了未添加配体时GPR6的晶体结构(一种假无配体状态)以及与两种反向激动剂形成的复合物的晶体结构,其中包括CVN424,该药物在临床试验中改善了帕金森病患者的运动症状。此外,我们还获得了GPR6与其同源G异源三聚体之间信号复合物的冷冻电镜结构。假无配体结构显示GPR6的正构口袋中有一个与类脂内源性配体相对应的强电子密度。定点诱变、天然质谱和计算机建模相结合,揭示了GPR6高组成性活性和反向激动作用的潜在机制,并确定了一系列与该受体结合的脂质和离子。本研究获得的结构和结果可为调节GPR6信号传导的药物合理设计提供指导。

相似文献

5
Helicobacter pylori eradication for Parkinson's disease.根除幽门螺杆菌治疗帕金森病。
Cochrane Database Syst Rev. 2011 Nov 9(11):CD008453. doi: 10.1002/14651858.CD008453.pub2.
7
Bromocriptine versus levodopa in early Parkinson's disease.早期帕金森病中溴隐亭与左旋多巴的对比
Cochrane Database Syst Rev. 2000(3):CD002258. doi: 10.1002/14651858.CD002258.
9
Amantadine in Parkinson's disease.金刚烷胺在帕金森病中的应用。
Cochrane Database Syst Rev. 2003;2003(1):CD003468. doi: 10.1002/14651858.CD003468.
10
Optimization of the prostaglandin F2α receptor for structural biology.用于结构生物学的前列腺素F2α受体的优化
PLoS One. 2025 Jul 18;20(7):e0320114. doi: 10.1371/journal.pone.0320114. eCollection 2025.

本文引用的文献

2
Identification of oleic acid as an endogenous ligand of GPR3.鉴定出油酸是 GPR3 的内源性配体。
Cell Res. 2024 Mar;34(3):232-244. doi: 10.1038/s41422-024-00932-5. Epub 2024 Jan 29.
4
Structural insight into the constitutive activity of human orphan receptor GPR12.对人类孤儿受体GPR12组成性活性的结构洞察。
Sci Bull (Beijing). 2023 Jan 15;68(1):95-104. doi: 10.1016/j.scib.2022.12.023. Epub 2022 Dec 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验